Evidence map›Paper›PMID 30424300›Full record

ArticleMicromachines2018

The Development of an Effective Bacterial Single-Cell Lysis Method Suitable for Whole Genome Amplification in Microfluidic Platforms.

Yuguang Liu, Dirk Schulze-Makuch, Jean-Pierre de Vera, Charles Cockell, Thomas Leya, Mickael Baqué, Marina Walther-Antonio

Abstract read
In one paragraph

Article in Micromachines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Recent Advances in Bacterial Persistence Mechanisms.International journal of molecular sciences · 2023
    Review
  5. AssesSments ofFrontiers in microbiology · 2023
    Article
  6. Article
  7. A culture-free biphasic approach for sensitive and rapid detection of pathogens in dried whole-blood matrix.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Impact of Preanalytical and Analytical Methods on Cell-Free DNA Diagnostics.Frontiers in cell and developmental biology · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuguang LiuDepartment of Surgery, Division of Surgical Research, Mayo Clinic, Rochester, MN 55905, USA. liu.yuguang@mayo.edu.
Dirk Schulze-MakuchAstrobiology Group, Center of Astronomy and Astrophysics, Technical University, 10623 Berlin, Germany. schulze-makuch@tu-berlin.de.
Jean-Pierre de VeraGerman Aerospace Center (DLR), Institute of Planetary Research, Management and Infrastructure, Astrobiological Laboratories, 12489 Berlin, Germany. jean-pierre.devera@dlr.de.
Charles CockellSchool of Physics and Astronomy, University of Edinburgh, Edinburgh EH9 3FD, UK. c.s.cockell@ed.ac.uk.
Thomas LeyaFraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses (IZI-BB), Extremophile Research & Biobank CCCryo, 14476 Potsdam, Germany. Thomas.Leya@izi-bb.fraunhofer.de.ORCID 0000-0002-5630-2206
Mickael BaquéGerman Aerospace Center (DLR), Institute of Planetary Research, Management and Infrastructure, Astrobiological Laboratories, 12489 Berlin, Germany. Mickael.Baque@dlr.de.
Marina Walther-AntonioDepartment of Surgery, Division of Surgical Research, Mayo Clinic, Rochester, MN 55905, USA. WaltherAntonio.Marina@mayo.edu.

Funding

Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancerP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI Zhenkun Lou · 2009 to 2026
$37.0M
ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
Institutional Career Development CoreKL2TR002379 · NCATS · MAYO CLINIC ROCHESTER · PI NILUFER ERTEKIN-TANER · 2017 to 2026
$14.9M
NCATS NIH HHS KL2 TR002379NCI NIH HHS P50 CA136393NCRR NIH HHS M01 RR000585The Ivan Bowen Family Foundation NA
6 · The paper itself

Abstract

Single-cell sequencing is a powerful technology that provides the capability of analyzing a single cell within a population. This technology is mostly coupled with microfluidic systems for controlled cell manipulation and precise fluid handling to shed light on the genomes of a wide range of cells. So far, single-cell sequencing has been focused mostly on human cells due to the ease of lysing the cells for genome amplification. The major challenges that bacterial species pose to genome amplification from single cells include the rigid bacterial cell walls and the need for an effective lysis protocol compatible with microfluidic platforms. In this work, we present a lysis protocol that can be used to extract genomic DNA from both gram-positive and gram-negative species without interfering with the amplification chemistry.

Indexed as

bacteria lysis protocolmicroalgae lysissingle-cell multiple displacement amplification

Identifiers

PMID30424300
PMCPMC6187716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.